MicroWash Nasal Lavage Device
Upper Respiratory Infection (URI) Testing / Sample Collection
CommercialActive
Key Facts
Indication
Upper Respiratory Infection (URI) Testing / Sample Collection
Phase
Commercial
Status
Active
Company
About MicroWash
MicroWash, developed by University Medical Devices, is commercializing a patented nasal lavage device that represents a potential paradigm shift in respiratory specimen collection. The device claims significant advantages over nasal swabs, including up to 49% greater PCR sensitivity, a three-year shelf life, a defined reimbursement pathway, and a vastly improved patient comfort rating (0.3/10 vs. 8/10 for swabs). Targeting the diagnostics and digital health sectors, the company is leveraging its leadership's clinical and biocontainment expertise to establish MicroWash as the new gold standard for nasal sampling in a post-pandemic world.
View full company profile